Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment

Clinical trial NCT01031875 · COMPLETED

Trial details

NCT number: NCT01031875
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer

Start date: 2009-12-01
Primary completion: 2011-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.